Sulfonylureas are the oldest class of oral antidiabetic medication dating back to the 1950s.

Sulfonylureas are comparable in efficacy and decrease the glycated hemoglobin A1C (HbA1c) by 1% to 1.25%.

Similar to sulfonylureas, meglitinides stimulate the pancreatic beta cells to secrete insulin.